MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $78,271 | -92.6% | 20,928 | -86.1% | 0.00% | – |
| Q1 2024 | $1,057,676 | +178.2% | 150,025 | +123.0% | 0.00% | – |
| Q4 2023 | $380,126 | +41580.5% | 67,279 | -42.5% | 0.00% | -100.0% |
| Q1 2023 | $912 | -69.5% | 117,094 | -70.2% | 0.00% | -50.0% |
| Q4 2022 | $2,992 | -98.6% | 393,150 | +1416.3% | 0.00% | – |
| Q3 2022 | $212,000 | +26.2% | 25,929 | +49.0% | 0.00% | – |
| Q2 2022 | $168,000 | -95.7% | 17,403 | -90.1% | 0.00% | -100.0% |
| Q3 2021 | $3,909,000 | -26.8% | 175,445 | -25.4% | 0.00% | -33.3% |
| Q2 2021 | $5,337,000 | – | 235,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $10,085,467 | 4.94% |
| NEA Management Company, LLC | 7,692,298 | $52,692,241 | 4.02% |
| Alphabet Inc. | 1,464,015 | $10,028,502 | 0.54% |
| Avoro Capital Advisors LLC | 4,535,000 | $31,064,750 | 0.42% |
| Casdin Capital, LLC | 510,882 | $3,499,542 | 0.31% |
| Baker Brothers Advisors | 3,023,951 | $20,714,064 | 0.12% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $213,419 | 0.07% |
| ExodusPoint Capital Management, LP | 669,495 | $4,586 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $193,115 | 0.03% |
| Octagon Capital Advisors LP | 19,900 | $136,315 | 0.02% |